
USA - NYSE:CNVY - US21258C1080 - Common Stock
The current stock price of CNVY is 10.51 USD. In the past month the price decreased by -0.1%. In the past year, price increased by 29.91%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.38 | 48.08B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.26 | 9.29B | ||
| WAY | WAYSTAR HOLDING CORP | 26.36 | 6.74B | ||
| HTFL | HEARTFLOW INC | N/A | 2.33B | ||
| CERT | CERTARA INC | 16.66 | 1.34B | ||
| PHR | PHREESIA INC | N/A | 1.30B | ||
| SDGR | SCHRODINGER INC | N/A | 1.30B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.22B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.49 | 1.03B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 624 | 1.06B | ||
| HSTM | HEALTHSTREAM INC | 35.99 | 725.29M |
Convey Health Solutions Holdings, Inc. engages in the provision of technology enabled solutions. The company is headquartered in Fort Worth, Florida and currently employs 3,510 full-time employees. The company went IPO on 2021-06-16. The company is a solution-oriented partner to payors and delivers technology and services to enhance its clients workflows. Its solutions address health plan needs, including product development and sales, member experience management, clinical management, core operations, business intelligence and analytics. The company operates through two segments: Technology Enabled Solutions (TES), which provides technology and support solutions to its clients, and Advisory Services, which provides project-based consulting services through its long-tenured subject matter experts. The company serves as a unified and integrated extension of its clients core health plan operations. Its clients are primarily MA plans, Medicare Part D plans (PDP) including Employer Group Waiver plans and pharmacy benefit managers (PBM).
Convey Health Solutions Holdings Inc
100 Se 3Rd Avenue, 26Th Floor
Fort Worth FLORIDA US
CEO: Stephen C. Farrell
Employees: 3510
Phone: 18005599358.0
Convey Health Solutions Holdings, Inc. engages in the provision of technology enabled solutions. The company is headquartered in Fort Worth, Florida and currently employs 3,510 full-time employees. The company went IPO on 2021-06-16. The company is a solution-oriented partner to payors and delivers technology and services to enhance its clients workflows. Its solutions address health plan needs, including product development and sales, member experience management, clinical management, core operations, business intelligence and analytics. The company operates through two segments: Technology Enabled Solutions (TES), which provides technology and support solutions to its clients, and Advisory Services, which provides project-based consulting services through its long-tenured subject matter experts. The company serves as a unified and integrated extension of its clients core health plan operations. Its clients are primarily MA plans, Medicare Part D plans (PDP) including Employer Group Waiver plans and pharmacy benefit managers (PBM).
The current stock price of CNVY is 10.51 USD. The price decreased by -0.47% in the last trading session.
CNVY does not pay a dividend.
CNVY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
CNVY stock is listed on the New York Stock Exchange, Inc. exchange.
Convey Health Solutions Holdings Inc (CNVY) will report earnings on 2022-11-09, after the market close.
You can find the ownership structure of Convey Health Solutions Holdings Inc (CNVY) on the Ownership tab.
ChartMill assigns a technical rating of 6 / 10 to CNVY. When comparing the yearly performance of all stocks, CNVY is one of the better performing stocks in the market, outperforming 94.07% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to CNVY. While CNVY is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months CNVY reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS increased by 28.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1.9% | ||
| ROA | -0.76% | ||
| ROE | N/A | ||
| Debt/Equity | 0.5 |
9 analysts have analysed CNVY and the average price target is 11.22 USD. This implies a price increase of 6.76% is expected in the next year compared to the current price of 10.51.
For the next year, analysts expect an EPS growth of 406.25% and a revenue growth 19.05% for CNVY